Mc Elhenny Sheffield Capital Management, LLC Alkermes Plc. Transaction History

Mc Elhenny Sheffield Capital Management, LLC

$303 Million
Q3 2024

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Jul 22, 2022	BUY	$26.4 - $30.54 $702,240 - $812,364	26,600 New	26,600 $792,000

Others Institutions Holding ALKS

# of Institutions

363

Shares Held

181M

Call Options Held

175K

Put Options Held

96.6K

Black Rock Inc. New York, NY

29.1M
Shares

$827 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

19M
Shares

$539 Million
0.01% of portfolio
Price T Rowe Associates Inc Baltimore, MD

13M
Shares

$369 Million
0.04% of portfolio
Wellington Management Group LLP Boston, MA

12.7M
Shares

$360 Million
0.06% of portfolio
State Street Corp Boston, MA

9.19M
Shares

$261 Million
0.01% of portfolio

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.67B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Elhenny Sheffield Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Elhenny Sheffield Capital Management, LLC with notifications on news.

Account